New FDA Policy Takes Aim At Big Compounders
By Jeff Overley · March 23, 2018, 7:13 PM EDT
The U.S. Food and Drug Administration on Friday moved to limit the operations of large drug compounders, laying out policies that could dramatically curb their ability to sell cheaper versions of...
To view the full article, register now.